CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-17 | Rajkovic Aleksandar Director | Grant or award · Stock Option (right to buy) | +194,986 | 194,986 | ||
| 2022-02-15 | Shams Soheil Chief Informatics Officer | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2022-02-15 | Shippy Richard Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2022-02-15 | Stewart Christopher P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2022-02-15 | Chaubey Alka Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2022-02-15 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2022-02-15 | Holmlin R. Erik President and CEO | Grant or award · Stock Option (Right to Buy) | +1,400,000 | 1,400,000 | ||
| 2021-12-21 | Wong Vincent Jung-Fai Director | Grant or award · Stock Option (Right to Buy) | +122,054 | 122,054 | ||
| 2021-11-29 | Holmlin R. Erik President and CEO | Purchase | +2,200 | $3.99 | $9K | 2,200 |
| 2021-11-29 | Holmlin R. Erik President and CEO | Purchase | +2,675 | $3.99 | $11K | 4,875 |
| 2021-11-29 | Holmlin R. Erik President and CEO | Purchase | +150 | $3.98 | $597 | 5,025 |
| 2021-11-19 | Stewart Christopher P. Chief Financial Officer | Option exercise | +22,500 | $0.56 | $13K | 55,500 |
| 2021-11-19 | Stewart Christopher P. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −22,500 | 177,500 | ||
| 2021-11-01 | Shams Soheil Chief Informatics Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2021-10-18 | Shams Soheil Chief Informatics Officer | Grant or award | +5,325,378 | 5,325,378 | ||
| 2021-08-17 | BARKER DAVID L Director | Grant or award · Stock Option (right to buy) | +40,751 | 40,751 | ||
| 2021-08-17 | Luderer Albert Director | Grant or award · Stock Option (right to buy) | +40,751 | 40,751 | ||
| 2021-08-17 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (right to buy) | +40,751 | 40,751 | ||
| 2021-08-17 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +40,751 | 40,751 | ||
| 2021-08-17 | Mamuszka Hannah Director | Grant or award · Stock Option (right to buy) | +40,751 | 40,751 |
Page 7 of 14 · 266 trades